J Mov Disord.
2025 Jan;18(1):31-34. 10.14802/jmd.24182.
Brittle Response to Levodopa as a Marker of Parkinson’s Disease Phenotype Characterized by Heavy Motor and Non Motor Burden
- Affiliations
-
- 1Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Salerno (SA), Italy
- 2Edmond J. Safra Program in Parkinson’s Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN. Division of Neurology, University of Toronto, Toronto, Canada
- 3Krembil Brain Institute, Toronto, Canada
- 4Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Canada
- 5Department of Parkinson’s Disease & Movement Disorders Rehabilitation, Moriggia-Pelascini Hospital–Gravedona ed Uniti, Como, Italy
- KMID: 2564043
- DOI: http://doi.org/10.14802/jmd.24182
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Residual Motor Disability After Levodopa Supplement in Parkinsonian Patients
- Association between Parkinson's Disease and Helicobacter Pylori
- Psychosis in Parkinson
- A Case of Dopamine Dysregulation Syndrome and Repetitive Behavior Caused by Levodopa in Parkinson's Disease
- Levodopa-induced respiratory dysfunction in Parkinson’s disease managed with subthalamic nucleus deep brain stimulation
